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Neutrophils contribute to pathogen clearance by
producing neutrophil extracellular traps (NETs),
which are genomic DNA-based net-like structures
that capture bacteria and fungi. Although NETs also
express antiviral factors, such as myeloperoxidase
and a-defensin, the involvement of NETs in antiviral
responses remains unclear. We show that NETs
capture human immunodeficiency virus (HIV)-1 and
promote HIV-1 elimination through myeloperoxidase
and a-defensin. Neutrophils detect HIV-1 by Toll-like
receptors (TLRs) TLR7 and TLR8, which recognize
viral nucleic acids. Engagement of TLR7 and TLR8
induces the generation of reactive oxygen species
that trigger NET formation, leading to NET-depen-
dent HIV-1 elimination. However, HIV-1 counteracts
this response by inducing C-type lectin CD209-
dependent production of interleukin (IL)-10 by den-
dritic cells to inhibit NET formation. IL-10 suppresses
the reactive oxygen species-dependent generation
of NETs induced upon TLR7 and TLR8 engagement,
resulting in disrupted NET-dependent HIV-1 elimi-
nation. Therefore, NET formation is an antiviral re-
sponse that is counteracted by HIV-1.
INTRODUCTION
Neutrophils play a pivotal role in the elimination of pathogens
invading a host (Papayannopoulos and Zychlinsky, 2009).
Recent studies have revealed that neutrophils undergo suicide
that is beneficial for host defense, releasing net-like structures
into the extracellular space to prevent the spreading of bacteriaCell Hand fungi (Brinkmann et al., 2004; Urban et al., 2009). The extra-
cellular structures are composed of genomic DNA and histones,
and are designated neutrophil extracellular traps (NETs) (Brink-
mann et al., 2004). Mitochondrial DNA is also a component of
NETs (Yousefi et al., 2009). Eosinophils and mast cells also
produce DNA-based NET-like structures to prevent the spread-
ing of bacteria (von Ko¨ckritz-Blickwede et al., 2008; Yousefi
et al., 2008).
Reactive oxygen species (ROS) andmitogen-activated protein
kinase (MAPK) mediate NET formation induced by phorbol
myristate acetate (PMA), a potent inducer of NET formation
(Fuchs et al., 2007; Papayannopoulos et al., 2010; Hakkim
et al., 2011). MAPK activates nicotinamide adenine dinucleotide
phosphate (NADPH) oxidase to induce ROS generation in
response to PMA. ROS damage the membrane of secretory
granules and lysosomes, and induce the translocation of neutro-
phil elastase from these organelles to the nucleus. Neutrophil
elastase then promotes the cleavage of histones, leading to
chromatin release into the cytosol.
NETs are highly sticky and capture extracellular microbes
such as bacteria and fungi (Brinkmann et al., 2004; Urban
et al., 2009). Furthermore, various antimicrobial factors,
such as cathelicidin, calprotectin, myeloperoxidase (MPO), and
a-defensin, are expressed on NETs to mediate the NET-depen-
dent elimination of bacteria and fungi (Brinkmann et al., 2004;
Urban et al., 2009). Although the pathological role of NETs
remains to be elucidated, NET formation is potently induced in
lungs of mice infected with influenza A virus and is affected
in neutrophils isolated from cats infected with feline immunode-
ficiency virus (Wardini et al., 2010; Hemmers et al., 2011;
Narasaraju et al., 2011).
Human immunodeficiency virus (HIV)-1 belongs to the lenti-
virus subfamily of retroviruses and infects human CD4+ T cells
and human macrophages (Haseltine, 1988). HIV-1 infection
disrupts the effectiveness of the human immune system and
renders hosts susceptible to opportunistic infections, leadingost & Microbe 12, 109–116, July 19, 2012 ª2012 Elsevier Inc. 109
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Figure 1. NETs Capture HIV-1
(A–C) Human neutrophils were stimulated with
PMA (1 mM) for 24 hr and were subsequently
incubated with or without an HIV-1 vector (p24
antigen, 1.0 ng/mL) for 6 hr. The samples were
fixed and subjected to SR-SIM. DNA and HIV-1
virions were detected by Hoechst 33342 and an
anti-HIV-1 p24 antibody, respectively (A). The ratio
of HIV-1 on NETs was determined (B). A three-
dimensional SR-SIM projection image and its
surface-rendering image are shown (C).
(D) Neutrophils stimulated with PMA were incu-
bated with the HIV-1 vector or the HIV-1 vector
lacking the envelope glycoprotein (HIV-1DEnv).
The samples were fixed and subjected to scanning
electron microscopy. The red arrows indicate
HIV-1 virions (120 nm spherical structures).
(E and F) Neutrophils with or without PMA stimu-
lation were treated with DNase I (50 U/mL) or left
untreated for 1 hr. The cells and NETs were then
incubated with the indicated dose of HIV-1 vector
(E) and HIV-1DEnv (F) for 6 hr. The levels of HIV-1
p24 in the culture supernatants and on the culture
plates were measured by ELISA. The data shown
are means ± SD (n = 3). Statistical significance
(p value) was determined by Student’s t test. *p <
0.01. See also Figure S1 and Movie S1.
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HIV-1 Elimination by NETsto the development of acquired immunodeficiency syndrome
(AIDS). Thus, elucidation of the antiviral response against
HIV-1 is clearly important. Although MPO and a-defensin which
are expressed on NETs, have the ability to inactivate HIV-1 (Kle-
banoff and Coombs, 1992; Moguilevsky et al., 1992; Ding et al.,
2009), there are few reports describing a role of NETs in the
elimination of HIV-1. Here, we examined the involvement of
NETs in the anti-HIV-1 host defense response.
RESULTS
MPO and a-Defensin Inactivate HIV-1 Captured by NETs
Human neutrophils produced NETs consisting of DNA after
PMA stimulation (see Figure S1A available online). The size and
formation ratio of the NETs were defined by the strength of
the PMA stimulation. Superresolution structured illumination110 Cell Host & Microbe 12, 109–116, July 19, 2012 ª2012 Elsevier Inc.microscopy (SR-SIM), a recently devel-
oped imaging technique (Schermelleh
et al., 2010), enabled us to observe the
structure of the NETs at high resolution,
and revealed that the NETs formed
multilobulated structures composed of
twisted DNA-based fibers (Figure S1B).
Scanning electron microscopy (SEM)
further confirmed that net-like structures
were produced by neutrophils in the
extracellular space (Figure S1C).
We used SR-SIM to detect HIV-1
virions, because conventional fluores-
cence microscopy is unable to detect
a single HIV-1 virion with sizes of less
than 200 nm, the theoretical resolutionlimit (Schermelleh et al., 2010). SR-SIM revealed that HIV-1
virions were captured on the outer face and in a ditch of the
NETs (Figures 1A–1C). Consistently, SEM revealed that the
NETs produced by neutrophils bound to HIV-1 virions as
120 nm spheres (Figure 1D). The HIV-1 Gag protein was de-
tected on the culture plates after stimulation of neutrophils with
PMA, but was not detected after DNase I treatment (Figure 1E),
indicating that the capture and removal of HIV-1 from the culture
supernatant were dependent on DNA on the culture plates. The
HIV-1 envelope glycoprotein was not involved in the binding of
HIV-1 virions to the NETs (Figures 1D and 1F). A moment of
NET binding to HIV-1 virions was observed by the time-lapse
imaging analysis (Movie S1). Since histones, major components
of NETs, are rich in positively charged basic amino acids, extra-
cellular histones could attract the negatively charged envelope
of HIV-1 virions. Consistently, HIV-1 virions were detected on
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Figure 2. MPO and a-Defensin Mediate
NET-Dependent Inactivation of HIV-1
(A–C)HumanneutrophilswithorwithoutPMA (1mM)
stimulation were treated with DNase I (50 U/mL) or
left untreated for 1 hr. The cells and NETswere then
incubated for 6 hrwith anHIV-1 vector (p24 antigen,
1.0 ng/mL). The infectivity of the HIV-1 vector in the
culture supernatant and on the culture plate was
determined (A). The levels ofHIV-1p24 in the culture
supernatants and on the culture plates were
measured by ELISA (B). A ratio of HIV-1 infectivity
per HIV-1 p24 was presented as infection index
(arbitrary units) (C). The results shown are means ±
SD (n = 3). Statistical significance (p value) was
determined by Student’s t test. *p < 0.01.
(D) Neutrophils were stimulated with PMA. The
samples were fixed and subjected to immunoflu-
orescence for MPO or a-defensin.
(E) Neutrophils with PMA stimulation were incu-
bated for 6 hr with an HIV-1 vector in the presence
of the indicated reagents. After removal of the
culture supernatant, the cells and NETs were
treated with DNase I for 1 hr to isolate the HIV-1
vector captured by the NETs. The infectivity of the
HIV-1 vector on the NETs was determined. The
data shown are means ± SD (n = 3). *p < 0.01.
DMSO, dimethyl sulfoxide; Ig, immunoglobulin.
(F) HIV-1 vector was incubated in the presence of
the indicated reagents for 6 hr. The infectivity of
the HIV-1 vector was determined. The data shown
are means ± SD (n = 3). See also Figure S2.
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HIV-1 Elimination by NETshistone H3 of the NETs (Figure S1D). Therefore, NETs capture
HIV-1 to prevent HIV-1 from spreading.
Next, we assessedwhether the infectivity of HIV-1 captured by
the NETs was altered. The infectivity of HIV-1 in the culture
supernatant was reduced after incubation with PMA-stimulated
neutrophils, but was not reduced after DNase I treatment
(Figures 2A–2C), indicating that DNA produced by PMA-stimu-
lated neutrophils mediates inactivation of HIV-1. Immunofluores-
cence analyses revealed that MPO and a-defensin were abun-
dantly expressed on the NETs produced by neutrophils
(Figure 2D, Figures S2A and S2B). Inhibition of MPO activity
and neutralization of a-defensin resulted in an impaired virucidal
response to HIV-1 on the NETs (Figure 2E). However, MPO inhib-
itor and anti-a-defensin-neutralizing antibody did not directly
affect infectivity of HIV-1 (Figure 2F). Although histones haveCell Host & Microbe 12, 109–an antimicrobial activity (Brinkmann
et al., 2004), HIV-1 inactivation by NETs
was not affected by neutralizing antibody
against histone H1 and H2 (data not
shown). Histone H3 and H4 might be
involved in HIV-1 inactivation by NETs.
These findings indicate that NETs ensure
high local concentrations of MPO and
a-defensin to inactivate HIV-1.
TLR7 and TLR8 Mediate HIV-1
Elimination by NETs
The finding of HIV-1 elimination by NETs
prompted us to assess whether the innateimmune system detects HIV-1 and induces NET formation. We
found that neutrophils efficiently produced NETs, which were
rich in MPO and a-defensin, after stimulation with HIV-1MN,
a replication-competent CXCR4-tropic HIV-1 strain (Figure 3A
and Figure S2C). Neutrophils also produced NETs after stimula-
tion with the CCR5-tropic strain HIV-1JR-FL and the HIV-1 vector
HIV-1CSII (Figure 3A). Neutrophils sensed HIV-1, resulting in the
capture of HIV-1 by NETs (Figure 3B). When CD4+ T cells and
neutrophils were cocultured, neutrophils reducedHIV-1 infection
efficiency in an extracellular DNA-dependent manner, indicating
that NETs inhibit HIV-1 infection of CD4+ T cells (Figure 3C).
These findings suggest that pathogen-recognition receptors ex-
pressed on neutrophils sense HIV-1 and induce the NET-depen-
dent HIV-1 elimination. Toll-like receptors (TLRs) are the sensors
for viruses that induce the antiviral response (Kawai and Akira,116, July 19, 2012 ª2012 Elsevier Inc. 111
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Figure 3. Neutrophils Sense HIV-1 by TLR7
and TLR8 to Produce NETs
(A) Human neutrophils were stimulated for 24 hr
with HIV-1MN (p24 antigen, 2.4 ng/mL), HIV-1JR-FL
(p24 antigen, 6.0 ng/mL), or HIV-1CSII vector (p24
antigen, 1.0 ng/mL). The samples were fixed and
subjected to Hoechst 33342 staining. The rates of
NET appearance were measured. The data shown
are means ± SD (n = 3).
(B) Neutrophils were stimulated with HIV-1MN for
24 hr. The samples were fixed and subjected to
SR-SIM. DNA and HIV-1 virions were detected by
Hoechst 33342 and an anti-HIV-1 p24 antibody,
respectively.
(C)CD4+ T cells (23 105 cells) were coculturedwith
neutrophils at the indicated T cell:neutrophil (T:N)
ratio. The cells were incubated with an HIV-1
vector in the absence or presence of DNase I
(50U/mL). The efficiency ofHIV-1 infection ofCD4+
T cells was determined. The results shown are
means ±SD (n = 3). Statistical significance (p value)
was determined by Student’s t test. *p < 0.01.
(D and E) Neutrophils were stimulated for 24 hr
with HIV-1MN in the presence of bafilomycin A1
(50 nM) or IRAK inhibitor (1 mM) (D). Neutrophils
were stimulated for 24 hr with HIV-1MN in the
presence of iODN2088 (1 mM), Dual-iODN (1 mM),
or G-type iODN (1 mM) (E). The rates of NET
appearance were measured. The data shown are
means ± SD (n = 3). *p < 0.01.
(F) CD4+ T cells were cocultured with neutrophils
at the indicated T cell:neutrophil ratio. The cells
were incubated with an HIV-1 vector in the
absence or presence of Dual-iODN. The efficiency
of HIV-1 infection of CD4+ T cells was determined.
The data shown are means ± SD (n = 3). *p < 0.01.
(G) Neutrophils were stimulated for 24 hr with R848
(100 nM) or CL075 (500 nM). The samples were
fixed and subjected to Hoechst 33342 staining.
(H and I) Neutrophils were stimulated with HIV-1
vector for 4 hr or R848 for 2 hr (H). Neutrophils
were pretreated with or without apocynin (1 mM)
for 30 min and subsequently stimulated with R848
for 2 hr (I). The cells were then stained with CM-
H2DCFDA (1 mM). The level of cytoplasmic ROS
was measured by FACS.
(J and K) Neutrophils were pretreated with or without BHA (100 mM) or apocynin for 30 min and subsequently stimulated with R848 for 24 hr. The rates of NET
appearance were measured (J). The cells and NETs were then treated with DNase I or left untreated and were subsequently incubated with an HIV-1 vector. The
infectivity of the HIV-1 vector in the culture supernatant was determined (K). The data shown are means ± SD (n = 3). *p < 0.01.
(L) Neutrophils were stimulated with R848 for 24 hr in the presence of anti-type I IFN receptor-neutralizing antibody or control isotype antibody. The cells and
NETs were then treated with DNase I or left untreated and were subsequently incubated with an HIV-1 vector. The infectivity of the HIV-1 vector in the culture
supernatant was determined. The data shown are means ± SD (n = 3). See also Figure S3.
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HIV-1 Elimination by NETs2009). In particular, TLR7 and TLR8 detect single-stranded RNA
of the HIV-1 genome on plasmacytoid dendritic cells to induce
the production of type I interferon, cytokines, and chemokines
(Beignon et al., 2005; Heil et al., 2004; Gringhuis et al., 2010).
Because multiple TLRs are expressed on neutrophils and
mediate ROS production (Hayashi et al., 2003; Hoarau et al.,
2007; Wang et al., 2008), we examined an involvement of the
TLR family members in NET formation induced by HIV-1. Inhibi-
tion of the vacuolar type H+-ATPase by bafilomycin A1 resulted
in the suppression of HIV-1-induced NET formation (Figure 3D),
suggesting that endolysosomal TLRs such as TLR3, TLR7,
TLR8, and TLR9 mediate NET formation. Chemical inhibition of112 Cell Host & Microbe 12, 109–116, July 19, 2012 ª2012 Elsevier Iinterleukin-1 receptor-associated kinase 4 (IRAK4), a critical
regulator of all TLRs except TLR3 (Kawai and Akira, 2009), also
resulted in the suppression of HIV-1-inducedNET formation (Fig-
ure 3D), suggesting that TLR7, TLR8, and TLR9 are involved in
NET formation. Neither bafilomycin A1 nor the IRAK4 inhibitor
suppressed NET formation by PMA, and these compounds did
not affect cell viability (Figures S3A and S3B). Dual-iODN and
iODN2088, antagonists for TLR7, TLR8, and TLR9, inhibited
NET formation by HIV-1, whereas G-type iODN, a selective
antagonist for TLR9, did not alter NET formation efficiency (Fig-
ure 3E). These inhibitory oligonucleotides did not affect NET
formation by PMA and cell viability (Figures S3C and S3D).nc.
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HIV-1 Elimination by NETsWhen CD4+ T cells and neutrophils were cocultured, neutrophils
reduced HIV-1 infection efficiency in a TLR7- and TLR8-depen-
dent manner (Figure 3F). These findings indicate that TLR7 and
TLR8 are responsible for the NET-dependent HIV-1 elimination.
We next examined the molecular mechanism of TLR7- and
TLR8-mediated NET formation. We focused on a role of ROS,
because NADPH oxidase-dependent ROS generation was
involved in the NET-dependent elimination of HIV-1 by PMA
(Figures S3E–S3G). Neutrophils produced NETs, which were
rich in MPO and a-defensin, in response to R848 and CL075,
synthetic ligands for TLR7 and TLR8 (Figure 3G and Figure S2D).
Both HIV-1 and R848 triggered the generation of ROS, and
R848-induced ROS generation was mediated by NADPH
oxidase (Figures 3H and 3I). Butylated hydroxyanisole (BHA),
a ROS scavenger, and apocynin, an inhibitor of NADPH oxidase,
inhibited the NET formation induced by R848, but did not alter
cell viability (Figure 3J and Figure S3H). Consistently, R848
induced NET-dependent HIV-1 elimination through ROS gener-
ated by NADPH oxidase (Figure 3K). Type I IFN, which is often
slightly induced by R848 (Kawai and Akira, 2009), was not
involved in NET-dependent HIV-1 elimination (Figure 3L). Thus,
TLR7 and TLR8 induce NADPH oxidase-dependent ROS gener-
ation to eliminate HIV-1 by NETs.
HIV-1 Induces CD209-Dependent IL-10 Production by
Dendritic Cells to Escape the NET-Dependent Antiviral
Response
Accumulating evidence has revealed that HIV-1 evolves to
manage immune cells, especially dendritic cells, for its efficient
propagation. For example, HIV-1 binds to the dendritic cell-
specific lectin CD209, also called DC-SIGN, to move along an
infectious synapse generated between CD209+ dendritic cells
and CD4+ T cells, resulting in efficient infection of CD4+ T cells
(Geijtenbeek et al., 2000; Arrighi et al., 2004). Since mucosal
tissues are rich in CD209+ dendritic cells and CD4+ T cells,
HIV-1 uses these tissues as major HIV-1 entry routes (Geijten-
beek et al., 2000; Jameson et al., 2002). Importantly, mucosal
tissues are also rich in neutrophils, and NETs are suggested to
be involved in themucosal inflammation (Mumy andMcCormick,
2009; Savchenko et al., 2011). Therefore, we assessed whether
HIV-1 makes use of CD209+ dendritic cells to escape the NET-
dependent antiviral response. Neutrophils produced NETs less
efficiently in response to R848 after exposure to the culture
supernatant of monocyte-derived dendritic cells incubated
with HIV-1 (Figure 4A). HIV-1 with the envelope glycoprotein,
but not HIV-1 lacking the envelope glycoprotein, induced the
production of a NET-suppressive factor by dendritic cells (Fig-
ure 4A). Consistently, recombinant gp120 induced the produc-
tion of the NET-suppressive factor by dendritic cells (Figure 4A).
CD4, CXCR4, and CD209 are known to bind to the envelope
glycoprotein of CXCR4-tropic HIV-1 and to induce an immune
response (Lee et al., 2003; Shan et al., 2007). An anti-CD209-
neutralizing antibody inhibited the production of the NET-
suppressive factor by dendritic cells stimulated with HIV-1, but
did not alter viability of dendritic cells and neutrophils (Figures
4B and 4C), indicating that HIV-1 stimulated CD209 on dendritic
cells to suppress TLR-mediated NET formation. However,
neither an anti-CD4-neutralizing antibody nor the CXCR4 antag-
onist T22 affected the production of the NET-suppressive factorCell Hby dendritic cells incubated with HIV-1 (Figure 4B). Thus, HIV-1
takes advantage of the functions of CD209 on dendritic cells
not only for efficient infection of the target cells but also to
escape the NET-mediated antiviral system.
Previous studies have revealed that the immunosuppressive
cytokine interleukin (IL)-10 is produced by dendritic cells after
engagement of CD209, and that the expression level of plasma
IL-10 correlates with the progression of AIDS (Stylianou et al.,
1999; Geijtenbeek et al., 2003; Shan et al., 2007; Naicker et al.,
2009). IL-33 is also produced by dendritic cells after engagement
of CD209 and suppresses inflammation through a unique TH2
pathway (Anthony et al., 2011). Next, we attempted to identify
the NET-suppressive factor produced by dendritic cells with
CD209 stimulation. An anti-IL-10-neutralizing antibody, but not
an anti-IL-33-neutralizing antibody, inhibited the suppression
of NET formation by the culture supernatant of dendritic cells
with CD209 stimulation (Figures 4D and 4E). When CD209+
dendritic cells and neutrophils were cocultured, dendritic cells
inhibited HIV-1-induced NET formation in a CD209- and IL-10-
dependent manner (Figure 4F), strongly suggesting that HIV-1
escapes from NETs under physiological conditions. Consis-
tently, dendritic cells produced IL-10 after sensing HIV-1 with
the envelope glycoprotein, but not HIV-1 lacking the envelope
glycoprotein (Figures 4G and 4H). Dendritic cells also produced
IL-10 after stimulation with recombinant gp120 (Figure 4H), indi-
cating that CD209 senses HIV-1 envelope glycoprotein to induce
IL-10 production. IL-10 inhibited the NET formation and NET-
dependent HIV-1 elimination induced by R848, but did not alter
cell viability (Figures 4I and 4J and Figure S3I). However, IL-10
failed to inhibit the NET formation and HIV-1 elimination induced
by PMA (Figures S3J and S3K). Therefore, HIV-1 induces
CD209-dependent production of IL-10 by dendritic cells to
suppress NET formation.
IL-10 is known to suppress the inflammatory immune
response by blocking activation of the TLR signaling pathway
(Chang et al., 2009). Phosphorylation of NCF1 is a key step in
activation of the NADPH oxidase complex (Johnson et al.,
1998; Dang et al., 2006). IL-10 inhibited R848-induced assembly
of p38 MAPK and NCF1 (Figure S4A) and phosphorylation of
NCF1 (Figure 4K). Consistently, IL-10 inhibited R848-induced
generation of ROS and subsequent nuclear translocation of
neutrophil elastase (Figure 4L and Figure S4B). However IL-10
did not inhibit NADPH oxidase-dependent ROS generation and
nuclear translocation of neutrophil elastase induced by PMA
(Figures S3L, S4A, and S4B). These findings indicated that
IL-10 inhibits TLR7- and TLR8-signaling pathway, resulting in
the suppression of NADPH oxidase-dependent NET formation.
DISCUSSION
In the present study, we have shown NET induction by the innate
immune system andHIV-1 elimination by NETs. Previous studies
have revealed that NETs also eliminate Staphylococcus aureus
and Candida albicans, causative agents of opportunistic infec-
tions in AIDS patients (Haseltine, 1988; Brinkmann et al., 2004;
Urban et al., 2009). Thus, induction of NET formation seems to
be a promising immunotherapeutic strategy for AIDS patients.
However, there are difficulties associated with eliminating
HIV-1 by NETs. This is because a progressive decrease in theost & Microbe 12, 109–116, July 19, 2012 ª2012 Elsevier Inc. 113
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Figure 4. HIV-1 Causes CD209-Dependent
IL-10 Production by Dendritic Cells to
Suppress NET Formation
(A) Human monocyte-derived dendritic cells (2 3
105 cells) were stimulated with or without HIV-1
vector (p24 antigen, 1.0 ng/mL), HIV-1DEnv, or
gp120 (1.0 mg/mL) for 24 hr. Seven days later,
autologous neutrophils (2 3 105 cells) were iso-
lated and treated with or without the indicated
culture supernatant of dendritic cells for 6 hr. The
cells were subsequently stimulated with or without
R848 (100 nM) for 24 hr. The rates of NET
appearance were measured. The results shown
are means ± SD (n = 3). Statistical significance
(p value) was determined by Student’s t test.
*p < 0.01. DC, dendritic cells; Sup., culture
supernatant.
(B) Dendritic cells were stimulated with HIV-1
vector for 24 hr in the presence of the CXCR4
antagonist T22, CD4-neutralizing antibody,
CD209-neutralizing antibody, or control isotype
antibody. Autologous neutrophils were pretreated
with or without the indicated culture supernatant of
dendritic cells for 6 hr and subsequently stimulated
with or without R848 for 24 hr. The rates of NET
appearance were measured. The data shown are
means ± SD (n = 3). *p < 0.01.
(C) Dendritic cells and neutrophils were cultured in
the presence of indicated reagents for 24 hr. The
cell viability wasmeasured by CellTiter-Glo kit. The
data shown are means ± SD (n = 3).
(D and E) Dendritic cells were stimulated with
HIV-1 vector for 24 hr. Autologous neutrophils
were pretreated for 6 hr with or without the culture
supernatant of HIV-1-stimulated dendritic cells in
the presence of anti-IL-10-neutralizing antibody
(D), anti-IL-33-neutralizing antibody (E), or control
isotype antibody. The neutrophils were subse-
quently stimulated with or without R848 for 24 hr.
The rates of NET appearance were measured. The
data shown are means ± SD (n = 3). *p < 0.01.
(F) Neutrophils and dendritic cells were stimulated
with HIV-1 vector for 24 hr in the presence of
CD209-neutralizing antibody, IL-10-neutralizing
antibody, or control isotype antibody. The rates of
NET appearance were measured. The data shown
are means ± SD (n = 3). *p < 0.01.
(G and H) Dendritic cells were stimulated for 24 hr
with or without HIV-1MN or HIV-1JR-FL (G). Dendritic
cells were stimulated for 24 hr with or without HIV-1 vector, HIV-1DEnv, or gp120 (H). The levels of IL-10 in the culture supernatants weremeasured by ELISA. The
data shown are means ± SD (n = 3). *p < 0.01.
(I and J) Neutrophils were pretreated with or without IL-10 (10 ng/mL) for 6 hr and subsequently stimulated with R848 for 24 hr. The rates of NET appearance were
measured (I). The cells and NETs were then treated with DNase I (50 U/mL) or left untreated, and subsequently incubated with an HIV-1 vector. The infectivity of
the HIV-1 vector in the culture supernatant was determined (J). The data shown are means ± SD (n = 3). *p < 0.01.
(K) Neutrophils were pretreated with or without IL-10 for 6 hr and subsequently stimulated with R848 for 1 hr. The cell lysates were subjected to immunoblotting
with antibodies against the indicated proteins.
(L) Neutrophils were pretreated with or without IL-10 for 6 hr and subsequently stimulated with R848 for 2 hr. The cells were then stained with CM-H2DCFDA
(1 mM). The level of cytoplasmic ROS was measured by FACS. See also Figure S4.
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HIV-1 Elimination by NETsnumber of neutrophils occurs in AIDS patients, and the host
defense systems are disrupted by HIV-1 (Scadden, 1992; Shan
et al., 2007; D’Souza et al., 2008). The severe neutropenia and
immune disruption by HIV-1 might complicate HIV-1 elimination
by the NET antiviral system and lead to the progression of AIDS.
To recover well from neutropenia, administration of granulocyte
monocyte colony-stimulating factor (GM-CSF) or granulocyte114 Cell Host & Microbe 12, 109–116, July 19, 2012 ª2012 Elsevier Icolony-stimulating factor (G-CSF) is effective (Scadden, 1992;
D’Souza et al., 2008). These growth factors stimulate the
survival, proliferation, differentiation, and function of neutrophil
precursors and mature neutrophils. In addition, GM-CSF has
the ability to assist NET formation (Martinelli et al., 2004). Inhibi-
tion of HIV-1 interactions with CD209may also support induction
of the NET antiviral system because IL-10 inhibits not only thenc.
Cell Host & Microbe
HIV-1 Elimination by NETsformation of NETs but also the activation of the G-CSF and
GM-CSF signaling pathways (Dang et al., 2006; Yoshimura
et al., 2007). Therefore, a combination therapy, with recovery
from neutropenia and inhibition of HIV-1 immune escape, may
be effective in AIDS patients.
EXPERIMENTAL PROCEDURES
Titration of HIV-1
Neutrophils (2 3 105 cells) were treated as indicated and then incubated for
6 hr with an HIV-1 vector capable of expressing firefly luciferase after integra-
tion into the host genome. Alternatively, the HIV-1 vector incubated for 6 hr in
the absence of neutrophils was used as input control. Molt-4 T cells (2 3 105
cells) were incubated with the culture supernatant for 48 hr to determine the
infectivity of the HIV-1 vector in the culture supernatant. Separately, Molt-4
T cells were seeded into a culture plate after harvesting of the culture superna-
tant and were incubated for 48 hr to determine the infectivity of the HIV-1
vector on the culture plate. After the incubation, the Molt-4 T cells were sub-
jected to a luciferase reporter assay. The luciferase activity in Molt-4 T cells
infected with the treated HIV-1 vector was divided by the luciferase activity
in Molt-4 T cells infected with the input HIV-1 vector to determine the infectivity
of the treated HIV-1 vector. The experiments were performed in accordance
with the guidelines of the ethics committee of Osaka University.
Immunocytochemistry
Immunofluorescence staining was performed as previously described (Saitoh
et al., 2011). The samples were examined under an IX81-DSU spinning disc
confocal microscope (Olympus). For measurement of the efficiency of NET
formation, 20 fields of view in each sample (each 1003 100 mm)were randomly
chosen for analysis. The number of views with NETs was counted to measure
the rate of NET appearance.
Superresolution images of the samples were obtained using an Elyra SR-
SIM (Zeiss). For measurement of the efficiency of HIV-1 capture by NETs,
six fields of view in each sample (each 5 3 5 mm) were randomly chosen for
analysis. Rendering of z stack SR-SIM images by the software Imaris (Bitplane
AG) was used to construct the three-dimensional SR-SIM image.
SEM Analysis
Samples on plastic coverslips were fixed with 2% formaldehyde and 2.5%
glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4), postfixed with 1% osmium
tetroxide and 0.5% potassium ferrocyanide in the same buffer, dehydrated
through a graded series of ethanol, substituted with t-butyl alcohol, and
freeze-dried. After freeze-drying, the samples were coated with osmium
tetroxide and observed with a S-4800 field emission scanning electron micro-
scope (Hitachi High-Technologies).
Immunoblotting
Immunoblotting was performed as previously described (Saitoh et al., 2011).
ELISA
The levels of HIV-1 p24 and IL-10 were measured by ELISA according to the
manufacturer’s instructions.
Fluorescence-Activated Cell Sorting
Fluorescence-activated cell sorting (FACS) was performed as previously
described (Saitoh et al., 2011).
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